Notable negative changes in fundamentals have recently occurred for USANA Health Sciences Inc (NYSE: USNA): significant quarterly sales deceleration occurred, the consensus estimate for December, 2024 decreased significantly, and the consensus estimate for December, 2025 decreased significantly.
USANA Health Sciences Inc (NYSE: USNA) has recently experienced significant negative changes in investment behavior: negative upside/downside volume developed.
In light of these highly negative signals we are reviewing our current Overall Rating of D. We would continue to view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
USNA is expected to continue to be a Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
USANA Health Sciences has a current Value Trend Rating of D (Negative). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. USANA Health Sciences has a neutral Appreciation Score of 52 but a poor Power Rating of 21, producing the Negative Value Trend Rating.
Recent Price Action
On 8/9/24, USANA Health Sciences Inc (NYSE: USNA) stock declined slightly by -0.6%, closing at $38.96. However, this decline was accompanied by normal trading volume at 83% of normal. The stock has declined -10.1% during the last week and has been weak relative to the market over the last nine months.
Be the first to comment